Amicus Therapeutics , Nasdaq: FOLD
A clinical-stage biotech company developing a treatment for genetic diseases.
Industry: Health Care
First Day Return: -3.8%
FOLD
A clinical-stage biotech company developing a treatment for genetic diseases.
| IPO Data | |
|---|---|
| IPO Date | 05/30/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Cranbury, NJ, United States |
| Founded | 2002 |
| Employees at IPO | n/a |
| Website www.amicustherapeutics.com | |
IPO News for Amicus Therapeutics
Amicus Therapeutics (FOLD) Performance
